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Abstract
Background: During transendothelial migration, leukocytes use adhesion molecules, such as ICAM-1, to adhere to the
endothelium. ICAM-1 is a dynamic molecule that is localized in the apical membrane of the endothelium and clusters upon
binding to leukocytes. However, not much is known about the regulation of ICAM-1 clustering and whether membrane
dynamics are linked to the ability of ICAM-1 to cluster and bind leukocyte integrins. Therefore, we studied the dynamics of
endothelial ICAM-1 under non-clustered and clustered conditions.
Principal Findings: Detailed scanning electron and fluorescent microscopy showed that the apical surface of endothelial
cells constitutively forms small filopodia-like protrusions that are positive for ICAM-1 and freely move within the lateral
plane of the membrane. Clustering of ICAM-1, using anti-ICAM-1 antibody-coated beads, efficiently and rapidly recruits
ICAM-1. Using fluorescence recovery after photo-bleaching (FRAP), we found that clustering increased the immobile fraction
of ICAM-1, compared to non-clustered ICAM-1. This shift required the intracellular portion of ICAM-1. Moreover, biochemical
assays showed that ICAM-1 clustering recruited beta-actin and filamin. Cytochalasin B, which interferes with actin
polymerization, delayed the clustering of ICAM-1. In addition, we could show that cytochalasin B decreased the immobile
fraction of clustered ICAM-1-GFP, but had no effect on non-clustered ICAM-1. Also, the motor protein myosin-II is recruited
to ICAM-1 adhesion sites and its inhibition increased the immobile fraction of both non-clustered and clustered ICAM-1.
Finally, blocking Rac1 activation, the formation of lipid rafts, myosin-II activity or actin polymerization, but not Src, reduced
the adhesive function of ICAM-1, tested under physiological flow conditions.
Conclusions: Together, these findings indicate that ICAM-1 clustering is regulated in an inside-out fashion through the actin
cytoskeleton. Overall, these data indicate that signaling events within the endothelium are required for efficient ICAM-1-
mediated leukocyte adhesion.
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Introduction
Leukocytes use integrins to firmly adhere to activated
endothelium through adhesion molecules such as VCAM-1 and
ICAM-1 prior to extravasation. Over the past years, the
endothelium is increasingly recognized to actively contribute to
the adhesion and transmigration of leukocytes [1]. Binding of
leukocyte integrin aL/Mb2 induces ICAM-1 clustering, resulting
in downstream signalling in the endothelium [2–5]. This
intracellular signalling induced into the endothelium regulates
rearrangement of the actin cytoskeleton. We and others have
shown increased stress fiber formation after ICAM-1 antibody
crosslinking [6,7]. These changes in the actin cytoskeleton imply
an important role for Rho-like small GTPases [8]. In agreement
with this notion, various studies have shown that RhoA, which
induces stress fibers and contractility, is activated downstream
from ICAM-1 clustering [6,9,10]. Blocking RhoA activity by C3
toxin or overexpression of a dominant negative mutant (RhoA-
T19N) prevents antibody-mediated and monocyte-induced clus-
tering of ICAM-1, monocyte adhesion and subsequent stress fiber
formation [11]. These data indicate that active RhoA is involved
in ICAM-1 function. In addition, upon clustering, either by
antibody-mediated crosslinking or by adhesion of THP-1 cells,
ICAM-1 is incorporated into detergent-insoluble membrane
domains, i.e. lipid rafts [12]. Interestingly, this shift to the
insoluble fraction is not inhibited by cytochalasin B, an inhibitor
of actin polymerization, suggesting that this response is indepen-
dent from RhoA.
Pioneering work from Barreiro and co-workers showed that
endothelial cells actively protrude sheets of membrane around an
adherent leukocyte, referred to as docking structures [13]. These
authors showed that several actin-binding proteins are present in
these structures, such as vinculin, paxillin, alpha-actinin, VASP
and ERM-proteins. From other reports, it became clear that the
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11336Figure 1. ICAM-1 clusters to leukocyte adhesion sites. (A) Left panel shows localization of endogenous ICAM-1 in green on endothelial
filopodia (Arrowheads). Middle panel shows localization of ICAM-1-GFP, expressed in HeLa cells on filopodia. Right panel shows scanning electron
microscopy (SEM) recording of TNF-a-pretreated HUVECs visualising small filopodia protruding out of the apical plane of the membrane
(arrowheads). Bars, 10 mm( B) Cos7 cells expressing GFP (left panel) or ICAM-1-GFP (right panel) were cultured on glass cover slips and analyzed by
SEM. ICAM-1-GFP but not GFP only-expressing Cos7 cells showed multiple filopodia (arrowheads). Bar, 10 mm. (C) TNF-a-pretreated HUVECs were
cultured on glass cover slips and calcein-red labelled differentiated HL60 cells were allowed to adhere for 30 minutes. Arrowheads show recruitment
of ICAM-1 to adherent HL60 cells. Images show ICAM-1 in green and HL60 cells in red. Right panel shows ICAM-1-GFP-transfected HeLa cells, cultured
on glass cover slips and calcein-red labelled differentiated HL60 cells adhered for 30 minutes. Bar, 10 mm. (D) ICAM-1-GFP-transfected Cos7 cells were
cultured on glass covers and aICAM-1-antibody coated beads (size 3 mm) adhered for 30 minutes. Arrowheads show recruitment of ICAM-1-GFP to
adhered beads. Images show ICAM-1-GFP in green, F-actin in red, merge in yellow and the beads in white. Note that the beads specifically adhered to
ICAM-1-GFP expressing cells. The asterisk shows non-transfected cell with no bead adhesion. Bar, 20 mm. (E) ICAM-1-GFP (green) is expressed in HeLa
cells and recruited (arrowheads) to aICAM-1-antibody coated beads (size 10 mm; asterisks). Quantification of ICAM-1 recruitment on the right shows
that ICAM-1-GFP is recruited to 25% of the beads after 36 minutes. Data are mean 6 SEM from four experiments.
doi:10.1371/journal.pone.0011336.g001
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PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e11336Figure 2. Lateral mobility of ICAM-1 depends on its C-terminal domain. (A) ICAM-1-GFP is expressed in HeLa cells and FRAP was measured.
Box in the upper panel depicts the FRAP region (square) and the recovery in time after every 10 seconds. Image at the right shows recovery after 200
seconds. Middle panel shows ICAM-1-GFP FRAP that is clustered around an adherent bead, coated with ICAM-1 antibodies. Lower image shows the
merge of the green channel and DIC, in which the bead is visible. Bars, 10 mm. (B) Quantification of the FRAP data show decreased ICAM-1-GFP
mobility following clustering. Graph on the left shows ICAM-1-GFP FRAP in time and graph on the right shows the difference in ICAM-1 mobility at
t=300 seconds. ICAM-1 was clustered using aICAM-1 antibody-coated beads. ICAM-1 FRAP was significantly reduced upon clustering. Experiment is
carried out 6 times. Data are mean 6 SEM. *p,0.01. (C) TNF-a-pretreated HUVECs were cultured on FN-coated surfaces and anti-ICAM-1-coated
magnetic beads were allowed to adhere to the endothelium for 30 minutes, resulting in clustering of ICAM-1, after which the cells were lysed. As a
control, the beads were added to endothelial cell lysates. Lysate conditions prevent ICAM-1 from clustering and these samples are therefore marked
as Non-clustered. Next, using a magnetic pen, the beads were isolated from the cell lysates, washed and analyzed using Western blotting. The images
on the left show that the magnetic beads efficiently precipitated ICAM-1 and that ICAM-1 clustering resulted in the recruitment of actin and filamin A
and B. Images on the right show the expression of indicated proteins in the cell lysates.
doi:10.1371/journal.pone.0011336.g002
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PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11336intracellular domain of ICAM-1 plays an essential role in its
function. Deleting the intracellular domain of ICAM-1 decreases
transendothelial migration (TEM) of leukocytes [14,15]. This was
further underscored by a study by Sans et al., in which they
expressed ICAM-1 in CHO cells that lack endogenous ICAM-1
[16], which was sufficient to reconstitute TEM. However,
expression of a C-terminally deleted mutant lf ICAM-1 severely
impaired efficient TEM. Recently, using expression in Cos cells,
Oh and colleagues defined the RKIKK motif within the
intracellular domain of ICAM-1 as critical for ICAM-1 function
[17]. These data point to the importance of ICAM-1 in TEM.
ICAM-1 exists as a dimer and can freely diffuse in the plasma
membrane [18]. Upon clustering by antibody-mediated cross-
linking, ICAM-1 reduces its lateral mobility, most likely because of
increased association of the intracellular tail to actin cytoskeleton-
binding proteins [19]. Although all these efforts, it is still not
known which signals and molecules regulate ICAM-1 function and
mobility.
In this study, we analysed ICAM-1 dynamics by using
fluorescence recovery after photobleaching (FRAP) prior to and
following ICAM-1 clustering. In addition, the adhesive function of
ICAM-1 was studied under flow. We show that ICAM-1 function
is regulated by the connection of its C-terminal intracellular
domain to downstream, cytoskeleton-regulating proteins myosin-II
and the small GTPase Rac1, but not Src-like kinases. Our data
provide evidence for control of ICAM-1 function in leukocyte
adhesion in an inside-out fashion through the modulation of
ICAM-1 lateral mobility and linkage to the actin cytoskeleton.
Materials and Methods
Reagents and Abs
Monoclonal antibody (mAb) against ICAM-1 was purchased
from R&D Systems (Minneapolis, MN); Polyclonal Abs against
ICAM-1 (for WB, no.7891) was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). ICAM-1-ALEXA 647 mAb
(Clone 15.2) was purchased from Serotec (Oxford, UK). The GFP
mAb was purchased from Invitrogen (Carlsbad, CA). Actin
antibody and Cytochalasin B were purchased form Sigma-Aldrich
(Zwijndrecht, the Netherlands). Recombinant Tumor-Necrosis-
Factor (TNF)-a was purchased from PeproTech (Rocky Hill, NJ);
Texas-Red Phalloidin, ALEXA 488-labelled GaM-Ig, ALEXA
568-labelled GaM-Ig, ALEXA 568-labelled GaR-Ig, ALEXA
488-labelled GaR-Ig and ALEXA 488-labelled streptavidin
secondary Abs were from Molecular Probes (Leiden, The
Netherlands) and all used in a 1:500 dilution. Jasplakinolide was
purchased from Merck KGaA (Darmstadt, Germany).
Expression Vectors
ICAM-1-wt-GFP was a kind gift from Dr. Sanchez-Madrid
(Madrid, Spain). The C-terminal deletion mutant was generated
by deleting the 27 aa at the C-terminus.
Cell cultures, treatments and transfections
Primary HUVECs (Human Umbilican Vein Endothelial cells)
were obtained from Cambrex (East Rutherford, NJ) and cultured
as described previously [10]. Endothelial cells were activated with
10 ng/ml TNF-a overnight to mimic inflammation. All cell lines
were cultured or incubated at 37uCa t5 %C O 2. The HL60 pro-
myelocytic cell line was routinely cultured in IMDM, supplement-
ed with 10% fetal bovine serum (Sigma). Where indicated,
DMSO-differentiated HL60 cells were used. Differentiation to a
neutrophil-like phenotype was achieved by including 1.3% DMSO
in the medium for 3–5 days which resulted in increased expression
of the LFA-1 and Mac-1 integrins [20]. Cos7 and Hela cells were
maintained in IMDM with 10% fetal bovine serum. Cells were
transiently transfected with the expression vectors indicated in
each experiment according to the manufacturer’s protocol using
LipofectAMINE PLUS (Invitrogen) or Fugene6 (Roche, Basel,
Swiss).
Immunofluorescence (IF)
Cells were cultured on FN-coated-glass cover slips, fixed and
immunostained with indicated primary Abs as described previ-
ously [7]. Subsequent visualization was performed with Alexa-
conjugated secondary Abs (Invitrogen). F-actin was visualized with
fluorescently-labeled Phalloidin (Invitrogen). Images were record-
ed with a ZEISS LSM510 confocal microscope with appropriate
filter settings. Crosstalk between the different channels was
avoided by use of sequential scanning.
Scanning electron microscopy
Transfected cells were grown on glass coverslips, fixed in 2.5%
glutaraldehyde/PBS for 30 min at room temperature, and
processed for scanning EM as described previously [10]. Cells
were examined on a scanning electron microscope (model 820;
JEOL) at 15 kV.
Antibody-coated beads
3- or 10-mm polystyrene beads (Polysciences, Inc.) were
pretreated with 8% glutaraldehyde overnight, washed five times
with PBS, and were incubated with 300 mg/ml ICAM-1 mAb
(R&D systems) or polyclonal rabbit Ab (Santa Cruz) according to
the manufacturer’s protocol. Magnetic goat-anti-mouse IgG Ab-
coated Dynabeads (Invitrogen) were coated with ICAM-1 or IgG
isotype control Abs according to the manufacturers’ protocol.
Adhesion under flow
HUVECs were cultured on FN-coated glass cover slips,
incubated with inhibitors as indicated, together with 1 mg/mL
aICAM-1 antibody-coated beads for 30 minutes. Next, shear flow
is introduced at 0.25dyn/cm
2 (200 mL/minute) for 5 minutes, and
then increased to 1.25dyn/cm
2 for 5 minutes. Next, flow was
increased every 5 minutes with 1.25dyn/cm
2 up to 6.25dyn/cm
2
Figure 3. Requirement of the intracellular domain of ICAM-1 for clustering. (A) ICAM-1-GFP full length or a construct lacking the
intracellular tail (ICAM-1-DC) were transfected in HeLa cells and cultured on glass covers. Full-length ICAM-1 localizes to filopodia whereas the DC-
mutant shows a more dispersed distribution. Images show ICAM-1 staining in green, F-actin in red and merge in yellow. Image on the right is a
magnification of the merge. Bars, 20 mm. (B) ICAM-1-GFP full length or DC was transfected in Cos7 cells that lack basal filopodia and images were
taken using a scanning electron microscope. Zoom shows filopodia in full-length or ICAM-1 DC expressing Cos7 cells, Bar, 1 mm. (C) Quantification of
filopodia in Cos7 cells shows that ICAM-1 full length induces filopodia with an average length of 750nm. The DC-mutant shows smaller and fewer
filopodia. Bar graph shows number of filopodia per Cos7 cell. Experiment is done three times. Data are mean 6 SEM. *p,0.01. **p,0.001. (D) Full
length and DC ICAM-1-GFP are expressed in HeLa cells. Left panel shows FRAP in time and right panel shows FRAP quantification after 5 minutes of
bleaching. ICAM-1-DC recovers significantly faster than full length ICAM-1. Experiment is done four times. Data are mean 6 SEM. *p,0.05. (E) Full
length and DC ICAM-1-GFP are expressed in HeLa cells and ICAM-1 clustering was induced through aICAM-1 antibody-coated beads. Left panel
shows FRAP in time and right panel shows FRAP quantification after 5 minutes of bleaching. Clustered ICAM-1-DC recovers significantly faster than
full length. Experiment is done four times. Data are mean 6 SEM. *p,0.05.
doi:10.1371/journal.pone.0011336.g003
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adherent leukocytes was counted per field of view. Note that the
inhibitors were included in the medium and thus were present
throughout the experiment.
Immunoprecipitation and Western blot analysis
Cells were grown to confluency on FN-coated dishes (50 cm
2),
washed twice gently with ice-cold Ca
2+-and Mg
2+-containing PBS
and lysed in 300 mL of lysis buffer (25 mM Tris, 150 mM NaCl,
10 mM MgCl2, 2 mM EDTA, 0.02% SDS, 0.2% deoxycholate,
1% NP-40, 0.5 mM orthovanadate with the addition of fresh
protease-inhibitor-cocktail tablets (Boehringer) pH 7.4). After 10
minutes on ice, cell lysates were collected and pre-cleared for 30
minutes at 4uC with Streptavidin beads (Sigma-Aldrich, 15 ml for
each sample). The supernatant, cleared by centrifugation
(14.000*g, 5 minutes at 4uC) was incubated with 15 ml protein
Streptavidin beads that were coated with the biotin-tagged S27D
or the control peptide, for 1 h at 4uC under continuous mixing.
The beads were washed 3 times in lysis buffer and proteins were
eluted by boiling in SDS-sample buffer containing 4% 2-
mercaptoethanol (Bio-Rad). The samples were analyzed by 10%
SDS-PAGE. Proteins were transferred to 0.45 mm nitro-cellulose
(Schleicher and Schnell Inc., NH) and the blots were first blocked
with 5% (w/v) low-fat milk in TBST for 1 h, subsequently
incubated at room temperature with the appropriate Abs for 1 h,
followed by 30 minutes incubation with HRP-conjugated
secondary Abs at RT. Between the various incubation steps, the
blots were washed 5 times with TBST and finally developed
with an enhanced chemiluminescence (ECL) detection system
(Amersham).
Statistics
Student-T test was used to calculate statistical significance.
Results
In the course of our studies on ICAM-1 dynamics in endothelial
cells, we noticed that ICAM-1 on the surface of endothelial cells as
well as ICAM-1-GFP, transfected in HeLa cells, localizes to small,
fibrillar structures (Fig. 1A). Subsequent scanning electron
microscopy analysis showed that the surface of the apical
membrane of the endothelium forms small filopodia-like protru-
sions (Fig. 1A), reminiscent of the ICAM-1-positive fibrils,
identified by fluorescent microscopy. Interestingly, transfection of
ICAM-1-GFP into Cos7 cells, which normally do not expose
filopodia [21], resulted in the induction of multiple filopodia
(Fig. 1B). These data showed that ICAM-1 induces the formation
of dorsal filopodia. Live-cell imaging of transfected HeLa cells
showed that ICAM-1-GFP-positive dorsal filopodia are highly
motile (Movie S1). ICAM-1 is well recognized for its adhesive
function in binding leukocytes, and we and others have shown
ICAM-1 to be concentrated in ring-like structures surrounding
adherent leukocytes. In contrast, there is relatively little knowledge
about the dynamics of ICAM-1 recruitment upon binding to an
adhered leukocyte. To study this, leukocytes were allowed to
adhere to TNF-a-treated endothelial cells and ICAM-1 distribu-
tion was analyzed. Using HL60 cells, we found ICAM-1
recruitment to sites of leukocyte adhesion (Fig. 1C). The same
effect was observed when leukocytes adhered to HeLa cells
expressing ICAM-1-GFP (Fig. 1C). To mimic leukocyte-induced
ICAM-1 clustering, we used polystyrene beads that were coated
with anti-ICAM-1 antibodies [10]. These antibodies efficiently
block leukocyte adhesion and thus target an essential epitope in the
extracellular domain of the ICAM-1 molecule [7]. The anti-
ICAM-1-antibody coated beads only adhered to ICAM-1-GFP
expressing cells and recruited ICAM-1-GFP to sites of bead
adhesion in a similar fashion as the leukocytes (Fig. 1D and 1E).
Additional experiments showed that ICAM-1-GFP co-localized
with endogenous ICAM-1 in endothelial cells and clustered
around adhered anti-ICAM-1-antibody coated beads (Fig. S1A
and S1B). To study the kinetics of ICAM-1 recruitment, the
recruitment of ICAM-1-GFP to sites of bead adhesion was
recorded in real-time using confocal laser scanning microscopy.
ICAM-1-GFP was transfected into HeLa-cells to avoid dimeriza-
tion with endogenous ICAM-1 in endothelial cells [18]. These
experiments showed that after 30 minutes, approximately 25% of
the anti-ICAM-1-antibody coated beads that adhered to ICAM-1-
GFP-positive cells recruited ICAM-1-GFP (Fig. 1E).
To focus in more detail on the dynamics of ICAM-1 distribution
in the plasma membrane, we used a FRAP (Fluorescence
Recovery After Photobleaching)-based approach. ICAM-1-GFP,
expressed in HeLa cells, was bleached within a small area of the
cell and the recovery of ICAM-1-GFP was monitored in real time.
The data showed that levels of ICAM-1-GFP were restored to
approximately 60% within 5 minutes after bleaching (Fig. 2A and
2B). This data shows that 30–35% of ICAM-1-GFP resides in the
so-called ‘immobile fraction’. Similar results were obtained when
ICAM-1-GFP was transiently transfected into endothelial cells
(data not shown). Interestingly, recovery of clustered ICAM-1-
GFP, induced by the anti-ICAM-1-antibody coated beads, was
significantly reduced (3764%), compared to non-clustered ICAM-
1-GFP (6162%; Fig. 2B). To calculate the immobile fraction of
ICAM-1-GFP, fluorescence recovery was measured when a
plateau phase at 5 minutes was reached. These data showed that
the immobile fraction of ICAM-1-GFP increased over 2-fold upon
clustering (2364% for not clustered ICAM-1-GFP compared to
6265% for clustered ICAM-1-GFP). This indicates that clustering
drives ICAM-1 into an immobile fraction.
Figure 4. Actin polymerization is required for the shift of ICAM-1 to the immobile fraction. (A) HUVECs were treated with Cytochalasin B
(CytoB; 5 mg/mL) for 10 minutes to block actin polymerization, fixed and analyzed by fluorescent microscopy. CytoB prevents ICAM-1 localization to
filopodia. Images show ICAM-1 staining in green and F-actin in red. Merge shows co-localization of ICAM-1 and F-actin. Bar, 20 mm. (B) ICAM-1-GFP is
expressed in HeLa cells and treated or not with CytoB. ICAM-1 is clustered as described in B. Left panel shows no difference in FRAP of non-clustered
ICAM-1 upon CytoB treatment. Panel at the right shows increased ICAM-1 FRAP when actin polymerization was blocked. Experiment is done three
times. Data are mean 6 SEM. *p,0.05. (C) Quantification of clustered and non-clustered ICAM-1 shows that ICAM-1-GFP recruitment upon clustering
is delayed upon CytoB treatment but not in non-clustered conditions. Experiment is repeated 3 times and data are mean 6 SEM. *p,0.05. (D) ICAM-
1-GFP is expressed in HeLa cells and recruited to aICAM-1-antibody coated beads as described under 1E. Quantification graph shows that ICAM-1-
GFP recruitment is delayed when actin polymerization is blocked. Experiment is repeated 3 times and data are mean 6 SEM. *p,0.05. (E) TNF-a-
pretreated HUVECs were cultured on FN-coated surfaces and prior to anti-ICAM-1-coated magnetic beads-induced clustering, cells were pretreated
with CytoB or jasplakinolide (10 mM). Next, beads were allowed to adhere to the endothelium for 30 minutes, and samples were processed as
described in the legend of figure 2C. Panels on the left show magnetic beads pull down. ICAM-1 was precipitated equally under all conditions.
Clustering of ICAM-1 induced the link to actin, which was prevented by CytoB pre-treatment. Stabilizing actin filaments by jasplakinolide promoted
the link of ICAM-1 with actin upon clustering. Panels on the right show the expression of indicated proteins in the cell lysates.
doi:10.1371/journal.pone.0011336.g004
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PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11336Figure 5. ICAM-1 requires filamin and its intracellular tail for the actin link and its motility. (A) TNF-a-pretreated HUVECs were cultured
on FN-coated surfaces and filamin expression was reduced using siRNA, according to Kanters et al. [22]. Next, anti-ICAM-1-coated magnetic beads
were allowed to adhere to the endothelium for 30 minutes, and samples were processed as described in the legend of figure 2C. Panels on the left
show magnetic beads pull down. ICAM-1 was precipitated equally in both conditions. Clustering of ICAM-1 induced the link to actin, which was
prevented by silencing Filamin A. Panels on the right show the expression of indicated proteins in the cell lysates. (B) Full length (FL) and DC ICAM-1-
GFP are expressed in M2 and A7 cells. Panel shows FRAP quantification. The data show that the recovery of full length ICAM-1 is faster in the absence
of filamin, e.g. in M2 cells. ICAM-1-DC-GFP FRAP is independent on the presence of filamin. Experiment is done three times. Data are mean 6 SEM.
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binds to clustered rather than to non-clustered ICAM-1. To study
if, in parallel, actin is recruited to clustered ICAM-1, we used
magnetic beads, coated with the ICAM-1 antibody, to pull-out
associating proteins. To do this, the beads were allowed to adhere
and to cluster ICAM-1 on intact, TNF-a-treated HUVEC for 30
minutes. Next, the beads were isolated by extraction from cell
lysates as described in Materials and Methods. As a control, the
magnetic beads were added post-lysis, preventing ICAM-1
clustering. Western blot analysis showed that the clustering of
ICAM-1 induced binding to actin (Fig. 2C). As a positive control,
we showed that filamin A and B bind selectively to clustered
ICAM-1, in line with our previous findings [22]. Filamin and actin
were also recruited to exogenous ICAM-1-GFP (Fig. S1C).
Moreover, by limiting the ICAM-1 clustering time, we could
show that actin and filamin were recruited in a time-dependent
manner to ICAM-1. After five minutes of clustering, no actin and
filamin was associated to ICAM-1. However, after 20 minutes of
clustering, actin and filamin were both precipitated with ICAM-1
(Fig. S1D). These data showed that clustering of ICAM-1
promotes binding to the actin cytoskeleton, possibly through
filamin A or B.
To determine whether the intracellular tail of ICAM-1 is
required for the shift of clustered ICAM-1 to the immobile
fraction, we used an ICAM-1-GFP mutant that lacks the
intracellular domain (ICAM-1-DC-GFP). ICAM-1-DC-GFP lo-
calized only to a limited extent to filopodia-like structures, as
compared to full-length ICAM-1 (Fig. 3A). Using scanning
electron microscopy, we found that Cos7 cells transfected with
full length ICAM-1 expressed large numbers of filopodia with an
approximate length of 750 nm (Fig. 3B and 3C). The number of
dorsal filopodia in the Cos7 cells that were transfected with ICAM-
1-DC was significantly reduced (Fig. 3B and 3C). In addition to
that, the average length of these filopodia was reduced to
approximately 200 nm (Fig. 3C). Interestingly, FRAP-analysis
showed that the mobility of non-clustered ICAM-1-DC was
significantly increased compared to full length ICAM-1 (Fig. 3D).
Moreover, a similar difference was observed when ICAM-1 was
clustered with aICAM-1-antibody coated beads, i.e. increased
recovery after bleaching of ICAM-1-DC compared to ICAM-1 full
length (Fig. 3E). In line with this, we found that 3767% of ICAM-
1-DC resides in the immobile fraction as compared to 6566% for
full length ICAM-1. These results underscore the importance of
the intracellular tail in the shift of ICAM-1 to the immobile
fraction.
Clustering of ICAM-1 resulted in increased accumulation of F-
actin at sites of binding of anti-ICAM-1-antibody coated beads or
adhesion of leukocytes [23]. Carman and co-workers already
showed by using cytochalasin B (CytoB) that F-actin is required for
the induction of apical cups, surrounding adherent lymphocytes
[24]. Our data showed that interfering with actin polymerization
using CytoB drastically reduced the number of ICAM-1-positive
dorsal filopodia (Fig. 4A). Next, we studied the role of actin
polymerization in the dynamics of ICAM-1-GFP. FRAP analysis
showed that basal dynamics of ICAM-1-GFP were not altered
following CytoB treatment (Fig. 4B). Interestingly, FRAP of
ICAM-1-GFP at sites of adhesion was significantly increased upon
inhibition of actin polymerization (Fig. 4B). Recalculation of the
immobile fraction showed that CytoB significantly reduced the
immobile fraction from 6367% to 3466%. Figure 4C showed the
quantification of the FRAP. In addition, when aICAM-1-antibody
coated beads were used to cluster ICAM-1-GFP, the recruitment
of ICAM-1 to sites of adhesion was delayed in CytoB-treated cells
as compared to untreated cells (Fig. 4D). Nevertheless, after
approximately 36 minutes of beads adhesion, the number of beads
that recruited ICAM-1 was similar in CytoB-treated and in control
cells. To study if blocking of actin polymerization affected the
linkage of ICAM-1 with actin, induced by clustering, a pull-out
assay using anti-ICAM-1-Ab coated magnetic beads was per-
formed, which showed that CytoB treatment prevented the
interaction of ICAM-1 with actin upon ICAM-1 clustering
(Fig. 4E). Interestingly, stabilizing actin filaments by jasplakinolide
promoted the interaction of ICAM-1 with actin upon clustering
(Fig. 4E). Thus, actin polymerization is required for ICAM-1
mobility and for efficient recruitment of ICAM-1 to sites of
adhesion.
We have previously shown that filamin links ICAM-1 to the
actin cytoskeleton [22]. In addition, reduction of filamin by siRNA
prevented the interaction of ICAM-1 with actin upon clustering
(Fig. 5A). These data indicate that filamin plays an important role
in the clustering-induced ICAM-1-actin association. To study if
filamin is also required in ICAM-1 motility, ICAM-1-GFP is
expressed in M2 melanoma cells. These cells lack the expression of
filamin and have been widely used in studies on actin regulation
[25,26]. As a control, filamin has been reconstituted in A7
melanoma cells. FRAP analysis of non-clustered ICAM-1-GFP
showed increased FRAP in M2 cells, indicating that filamin is
required for ICAM-1 motility (Fig. 5B). To study the importance
of the intracellular tail of ICAM-1 for its motility, we expressed
ICAM-1-DC-GFP into M2 and A7 cells and analyzed ICAM-1
motility by FRAP. Our data showed that no difference in the
motility of ICAM-1-DC-GFP was measured in the presence or
absence of filamin (Fig. 5B). To study the role of filamin after
ICAM-1 clustering, beads coated with ICAM-1 Ab were used.
FRAP analysis showed reduced motility of full length ICAM-1-
GFP in A7 cells, compared to the motility of ICAM-1-DC-GFP
(Fig. 5C). Interestingly, no difference in motility was measured
when ICAM-1-full length or DC were expressed in M2 cells
(Fig. 5C). In addition, these experiments have been repeated in
endothelial cells, in which filamin A expression was reduced using
siRNA. Similar results were obtained in these cells (data not
shown). Together, these data indicate that ICAM-1 needs its
intracellular tail and filamin for the mobility upon clustering.
Myosins are actin-based motors that regulate actin dynamics
[27]. Myosin-II co-localized with ICAM-1 at sites of aICAM-1
antibody-coated beads (Fig. 6A). Inhibiting myosin-II using
blebbistatin reduced ICAM-1-GFP dynamics, irrespective of
whether ICAM-1 was clustered or not (Fig. 6B). Tilghman and
Hoover showed that ICAM-1 shifts to lipid raft-rich membrane
domains upon clustering [12]. Preventing the formation of lipid
rafts by chelating cholesterol with methyl-b-cyclodextrin (b-CD)
reduced the dynamics of clustered ICAM-1-GFP significantly
(Fig. 6C). Interestingly, FRAP of non-clustered ICAM-1 was
unaltered (Fig. 6C). These data, together with results from the
ICAM-1-GFP FRAP analysis on CytoB-treated cells indicate that
the clustering of ICAM-1 depends on membrane composition and
*p,0.05. (C) Cells were transfected as described in B. ICAM-1-Ab coated beads were allowed to adhere for 30 minutes to cluster ICAM-1. FRAP was
measured at sites of bead adhesion in A7 (left panel) and M2 cells (right panel). Lower panel shows FRAP quantification. The data show that ICAM-1
requires filamin and its intracellular tail to shift to the immobile fraction upon clustering. Experiment is done four times. Data are mean 6 SEM.
*p,0.05.
doi:10.1371/journal.pone.0011336.g005
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remodeling.
The small GTPase Rac1 regulates the remodelling of the actin
cytoskeleton and induces membrane ruffles [28]. We recently
showed that Rac1 is activated upon clustering of ICAM-1 ([10];
Fig. S2A). To elucidate the role of Rac1 activity in ICAM-1
dynamics, we tested the Rac1-GEF inhibitor NSC-23766 on the
kinetics of ICAM-1 clustering. Using Trio-GEF-D1, a catalytic
active mutant of the exchange factor Trio, we showed that the
inhibitor indeed blocked Rac1 activity (Fig. S2B), as was also
shown by others [29]. Rac1 inhibition reduced the clustering of
ICAM-1-GFP to aICAM-1-antibody coated beads by approxi-
mately 50% (Fig. 7A). Next, we assessed the effects of this inhibitor
on ICAM-1-GFP dynamics by FRAP analysis. Interestingly, NSC-
Figure 6. Myosin and lipid raft formation are required for the shift of ICAM-1 to the immobile fraction. (A) TNF-a-pretreated HUVECs
were cultured on glass covers and images show ICAM-1 staining in green using ICAM-1-FITC to avoid cross-talk with the beads, myosin-II in red,
merge of ICAM-1 and myosin-II in yellow, F-actin in white and DIC is included to depict the beads (arrowheads). Myosin-II together with ICAM-1 is
clustered around the aICAM-1-antibody coated beads that were allowed to adhere for 30 minutes. Bar, 20 mm. Lower panel shows X-Z projection of
ICAM-1 in green and myosin-II in red (arrowheads) around the adhered aICAM-1-antibody coated beads (asterisk). White depicts F-actin. Bar, 5 mm.
(B) Cells were pretreated with 8 mM Blebbistatin to inhibit myosin-II for 30 minutes (Blebbi). ICAM-1-GFP FRAP was analyzed as described above and
showed that Blebbistatin significantly decreased the FRAP of non-clustered and clustered ICAM-1-GFP. Experiment is done three times. Data are
mean 6 SEM. *p,0.05. (C) Cells were pretreated with 5mM methyl-b-cyclodextrin for 30 minutes (b-CD). ICAM-1-GFP FRAP was analyzed as described
above and showed that b-CD did not affect ICAM-1-GFP FRAP of non-clustered ICAM1-GFP but significantly reduced the FRAP of clustered ICAM-1-
GFP. Experiment is done three times. Data are mean 6 SEM. *p,0.01.
doi:10.1371/journal.pone.0011336.g006
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1-GFP (Fig. 7B). This indicates that basal Rac1 activity is involved
in ICAM-1 mobility in the membrane. In addition, the recovery of
clustered ICAM-1-GFP was also significantly reduced upon Rac1
inhibition (Fig. 7B). These data underscore the importance of
Rac1 signaling controlling the dynamics of non-clustered as well as
clustered ICAM-1.
A key molecule that transmits ICAM-1-induced intracellular
signals is Src-kinase [30,31]. To assess the role of Src in ICAM-1
dynamics, we used Src-, Yes- and Fyn-kinase-deficient (SYF
-/-)
mouse embryonic fibroblast (MEF) cells or SYF
-/- MEFs stably
re-expressing Src (SYF
-/-+Src) (Fig. 8A). ICAM-1-GFP was
transfected into these cells and fluorescent analysis showed that
ICAM-1-GFP was localized in filopodia-like structures in both
cell types, albeit more clearly in the Src-reconstituted MEF cells
(Fig. 8B). FRAP-analysis showed that the dynamics of non-
clustered ICAM-1-GFP depended only minimally on the
presence of Src (Fig. 8C). Moreover, depletion of Src did not
affect the adhesion of anti-ICAM-1-antibody coated beads to
ICAM-1-GFP-positive MEFs (Fig. 8D). In addition, the use of
the classical inhibitors of Src-kinase PP1 and PP2 did not affect
the adhesion of anti-ICAM-1-antibody coated beads to endo-
thelial cells (data not shown). These data indicate that Src-kinase
plays only a minor role in the regulation of the dynamics of
ICAM-1.
Finally, we tested if the lateral mobility of ICAM-1 affects its
adhesive function under flow. The inhibitors used needed to be
Figure 7. Rac1 activity is required for optimal ICAM-1
dynamics. (A) Cells were pretreated with 100 mM NSC-23766 (NSC)
for 30 minutes. Quantification of ICAM-1 recruitment using aICAM-1
antibody coated beads shows that ICAM-1-GFP recruitment is reduced
upon inhibition of Rac1 activity by NSC. Experiment is repeated 3 times
and data are mean 6 SEM. *p,0.05. (B) ICAM-1-GFP FRAP was analyzed
as described in Materials and Methods and showed that NSC reduced
FRAP of non-clustered and clustered ICAM-1-GFP. Experiment is done
three times. Data are mean 6 SEM. *p,0.05.
doi:10.1371/journal.pone.0011336.g007
Figure 8. Src-kinase has no effect on ICAM-1 dynamics. (A)
Analysis of Src, Yes and Fyn-kinase (SYF)-deficient (SYF
-/-) or SYF
-/- with
reconstituted Src (SYF
-/-+Src) or control (CTRL) mouse embryonic
fibroblast (MEF) cells by western blotting using antibodies against Src,
Yes or Fyn. Tubulin was used for protein loading control. (B)
Immunofluorescent images show localization of ICAM-1-GFP in
filopodia in SYF
-/- or SYF
-/-+Src MEF cells. (C) Graph shows that the
expression of Src had only minor effect on the ICAM-1 FRAP in the SYF
-/-
cells. (D) aICAM-1 antibody coated beads (size 3 mm) were allowed to
adhere for 30 minutes on ICAM-1-GFP transfected SYF
-/- or SYF
-/-+Src
cells. Number of beads per ICAM-1-GFP-positive cell was counted. No
difference in adhesion of these beads the MEF cells is measured.
Experiment was carried out three times.
doi:10.1371/journal.pone.0011336.g008
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antibody-coated beads were used instead of leukocytes, since the
inhibitors may affect the function of the leukocytes. The beads
were allowed to adhere to the endothelium for 20 minutes,
followed by incubation with the inhibitors for 10 minutes. Then
flow was introduced, which gradually increased in time, as
described in Materials and Methods. These studies showed that
increasing the flow-rate resulted in a decreased adhesion of
aICAM-1 antibody-coated beads to the endothelium, indicating
that flow negatively regulates ICAM-1 function (Fig. 9A).
Subsequent blocking of actin polymerization or Rac1 activation
indicated that these are both needed for ICAM-1 function under
flow (Fig. 9A). Using blebbistatin or cyclodextrin, a steep
decrease in leukocyte adhesion was observed after an increase in
the flow-rate from 0.25dyn/cm
2 to 1.25dyn/cm
2 (Fig. 9B). Since
all inhibitors used in the flow assay reduced lateral mobility of
clustered ICAM-1, we conclude that optimal ICAM-1 mobility
is a prerequisite for ICAM-1 function to bind leukocytes to the
endothelium under physiological flow conditions. The findings
are summarized in figure 10.
Discussion
Leukocytes bind through their integrins LFA-1/Mac-1 to
endothelial ICAM-1 to establish firm adhesion. Upon leukocyte
binding, ICAM-1 translocates to sites of adhesion, forming a
typical ring structure around the adhered leukocyte [10,19,32,33].
Here, we show that upon clustering ICAM-1 shifts to an immobile
fraction in an actin-dependent manner, which also requires its
intracellular domain. In addition, actin-regulating proteins such as
Rac1 and myosin-II are involved in ICAM-1 dynamics, whereas
the polymerization of actin and the formation of lipid rafts are
necessary for the clustering.
Our recent work showed that filamin associates to ICAM-1 upon
clustering [22]. In this report, we show that clustering of ICAM-1
not only recruits filamin, but also beta-actin, illustrated in figure 10.
a-Actinin-1 and -4, other actin-binding proteins, are reported to
bind to the intracellular domain of ICAM-1 [34]. In addition, these
authors showed that a-actinin is required for proper leukocyte
extravasation.Throughthismolecule,ICAM-1maybelinkedtothe
actincytoskeleton.ThefamilyofERM-proteinshasbeenimplicated
in the direct link of ICAM-1 to the actin cytoskeleton as well [17].
Deletion of ezrin results in reduced ICAM-1-positive filopodia. The
authors furthermore show that deletion of the intracellular domain
of ICAM-1 prevents the interaction with ezrin and also reduces
filopodia. Our study indicates that deletion of the intracellular
domain of ICAM-1 results in smaller and reduced numbers of
filopodia. Adhesion of the leukocytes to tail-less ICAM-1 was not
affected under static or low shear stress conditions. However,
increasing the flow induces a loss of leukocyte adhesion to tail-less
ICAM-1, but not full length ICAM-1 [17]. These data indicate that
the intracellular domain plays an important role in ICAM-1
function, in line with previous reports [14,15]. Our current data
show that the intracellular domain of ICAM-1 is required for the
shift to the immobile fraction. From these data, it is clear that the
intracellular tail of ICAM-1, as well as the actin cytoskeleton is
required for proper ICAM-1 clustering, in order to function
efficiently as an adhesion molecule.
Figure 9. Quantification of ICAM-1 adhesion. (A) aICAM-1-
antibody coated-beads were allowed to pre-adhere to TNF-a-stimulated
endothelium for 5 minutes. Experiment was carried out as described in
Materials and Methods. Briefly, low shear was introduced (0.25dyn/cm
2)
and flow was increased stepwise with 1.25dyn/cm
2 at the time points,
indicated with arrows. The final shear corresponded to 6.25dyn/cm
2.
The aICAM-1-antibody coated beads detached from the endothelium
when shear increased. Pre-treatment of the endothelium with
cytochalasin B (CytoB) or NSC-23766 (NSC) showed a steeper decline
of detached beads upon increased shear flow. Experiment is done three
times. Data are mean 6 SEM. *p,0.05. (B) Experiment carried out as
described under A. Pre-treatment of the endothelial cells with either
blebbistatin (Blebbi) or cyclodextrin (b-CD) show a decrease in adhesion
of the beads to the endothelium, already after the first increase in shear
flow. Experiment is done three times in duplicate. Data are mean 6
SEM. *p,0.01.
doi:10.1371/journal.pone.0011336.g009
Figure 10. Schematic overview of ICAM-1 dynamics. ICAM-1
dynamics require Rac1 and myosin-II activity. Upon clustering, actin
polymerization and lipid raft formation play a pivotal role. These
signalling modules all affect the adhesive capacity of ICAM-1 under flow
conditions.
doi:10.1371/journal.pone.0011336.g010
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involved in ICAM-1 clustering, but appear to play a more general
role in ICAM-1 dynamics. Interfering with the activity of one of
these two molecules affects the lateral mobility of ICAM-1. Rac1
has not been implicated in ICAM-1 dynamics before, although
many studies have shown involvement of Rac1 activity in
membrane dynamics [28]. Interestingly, Heiska and colleagues
showed that PIP2 is required for proper binding of the actin-
binding protein ezrin to ICAM-1 [35]. Our lab and others have
previously shown that Rac1 associates to PIP-5-Kinase, which may
link Rac1 to PIP2-synthesis [36,37]. This suggests that Rac1 is
involved, through the regulation of inositol lipid turnover and the
regulation of ezrin, in linking ICAM-1 to the actin cytoskeleton
upon clustering. Myosin-II has not previously been implicated in
ICAM-1 dynamics. However, the fact that ICAM-1 localizes at
dorsal filopodia and moves within the lateral plane of the cells’
plasma-membrane makes myosin-II a possible candidate to be
involved in ICAM-1 dynamics. Recently, Khuon and colleagues
showed that myosin-II in endothelial cells forms a ring-like
structure that encapsulates an invading tumor cell [38]. Together
these findings suggest that Rac1 and myosin-II activity are
required for ICAM-1 dynamics.
The adhesive capacity of ICAM-1 can be tested using flow. By
applying increasing flow rates on an anti-ICAM-1 antibody-coated
bead bound to endothelium, the minimal flow rate that is required
for proper adhesion by ICAM-1 can be determined. We have used
beads instead of leukocytes for two reasons: First, the inhibitors
used need to be present throughout the experiment. This may
affect the leukocytes in their ability to bind to the endothelium.
Second, leukocytes adhere not only to ICAM-1 but also to ICAM-
2 and VCAM-1 and possibly other yet unidentified adhesion
molecules on activated endothelial cells. Thus, to avoid confusion,
we have used beads that specifically adhere to ICAM-1. Our
results indicate that actin polymerization, Rac1 signaling and in
particular myosin-II play a crucial role for optimal ICAM-1
adhesion (Fig. 10). The fact that actin polymerization is required
for the shift of ICAM-1 to the immobile fraction may explain why
ICAM-1 adhesion under flow is reduced following treatment of
cells with cytochalasin B. Under these conditions, ICAM-1 is not
efficiently anchored to the actin cytoskeleton which in turn results
in lower adhesive capacity.
It has been reported that blocking myosin light chain kinase
inhibits leukocyte transendothelial migration [39]. The authors
suggested that MLC-kinase acts on the cell-cell junctions and by
blocking its activity the junctions remain intact, resulting in a
reduced passage of leukocytes. We show that myosin-II is recruited
to sites of ICAM-1 adhesion and that blocking myosin-II activity
results in an impaired ICAM-1-mediated adhesion under flow. In
line with our data, Khuon and colleagues showed that myosin-II
activity is found at sites of adhesion [38]. These data underscore
the notion that ICAM-1 dynamics within the apical endothelial
membrane are essential for optimal ICAM-1 adhesive function.
Yang and co-workers showed that Src and cortactin play an
important role in the linking of ICAM-1 to the cytoskeleton [19].
These authors used pharmacological inhibitors to block Src activity.
We choose to use MEF cells that lack three Src-like kinases Src, Yes
and Fyn. Reconstitution of Src into these MEFs did not affect the
ICAM-1 mobility in the plane of the membrane as determined by
FRAP nor the adhesive function of ICAM-1. The latter finding is in
line with the results reported by Yang and colleagues. Therefore, we
concluded from these experiments that Src is not directly involved
in the adhesive function of ICAM-1, but rather in transmitting
intracellular signals downstream from ICAM-1 clustering, possibly
to regulate cell-cell junction integrity [30].
In conclusion, we postulate that the dynamics of ICAM-1 within
the plane of the membrane is vital for its function to induce firm
adhesion under physiological flow conditions. Our data emphasize
the contribution of ICAM-1 dynamics to its adhesive function and
may therefore represent an interesting target for future therapies to
reduce leukocyte accumulation to the vessel wall, as occurs in
diseases such as atherosclerosis and rheumatoid arthritis.
Supporting Information
Figure S1 ICAM-1-GFP co-localizes with endogenous ICAM-
1 and associates to filamin and actin upon clustering. (A) TNF-
a-stimulated endothelium was transiently transfected with
ICAM-1-GFP, fixed and stained for ICAM-1-GFP in green,
endogenous ICAM-1 in red. Merge shows co-localization in
yellow and F-actin is in grayscale. Images were taken from the
apical surface (upper panel) and at the baso-lateral plane (lower
panel). Bars, 50 mm. (B) Beads, coated with ICAM-1 Ab, were
allowed to adhere for 30 minutes to TNF-a-stimulated
HUVECs. ICAM-1 was stained using an ICAM-1 Ab that is
directly labelled with ALEXA 647. The results show that ICAM-
1-GFP (green) and endogenous ICAM-1 (red) co-localize
(Arrowheads; Merge in yellow) at sites of bead adhesion. DIC
image shows localization of the beads. Images were taken from
the apical surface (upper panel) and at the baso-lateral plane
(lower panel). Bars, 10 mm. (C) ICAM-1-GFP was transfected
into HeLa cells and anti-ICAM-1-coated magnetic beads were
allowed to adhere for 30 minutes, resulting in clustering of
ICAM-1, after which the cells were lysed ands treated as
described in the legend of figure 2C. The images on the left
show that the magnetic beads efficiently precipitated ICAM-1-
GFP and that ICAM-1 clustering resulted in the recruitment of
actin and filamin A. Images on the right show the expression of
indicated proteins in the cell lysates. (D) ICAM-1-GFP was
transfected into HeLa cells and anti-ICAM-1-coated magnetic
beads were allowed to adhere for 5 or 20 minutes, as indicated.
ICAM-1 was precipitated at both time points, whereas actin and
filamin A and B were associated to ICAM-1 only after 20
minutes of clustering. Images on the right show the expression of
indicated proteins in the cell lysates.
Found at: doi:10.1371/journal.pone.0011336.s001 (0.29 MB TIF)
Figure S2 Rac1 activation downstream from ICAM-1 cluster-
ing. (A) ICAM-1 was clustered using anti-ICAM-1-antibody
coated beads for 30 minutes on TNF-a-stimulated HUVECs.
Rac1 activity was measured based on a CRIB-pull down assay
from cell lysates. The results show that Rac1 is activated upon
clustering of ICAM-1 (Upper panel). Lower panel shows equal
levels of Rac1 in total cell lysates. (B) NSC-27632 inhibits Rac1
activity. HEK293 cells were transfected with GFP-Trio-D1, the
first DH/PH domain of the guanine nucleotide exchange factor
Trio and known to activate Rac1. The inhibitor (100 mM) is
incubated for 30 minutes and showed that Trio-D1-induced Rac1
activity was reduced. Rac1 activity was measured using a CRIB-
based pull down assay. The upper panel shows Rac1 activity, the
middle panel depicts the total Rac1 protein levels in the total cell
lysates and the lower panel shows the expression of the transfected
Trio-D1 constructs, stained with an anti-GFP antibody.
Found at: doi:10.1371/journal.pone.0011336.s002 (0.18 MB TIF)
Movie S1 Real-time recording of ICAM-1-GFP. HeLa cells
were transfected with ICAM-1-GFP full length and real-time
recording was taken from these cells for 45 minutes. Movie shows
small filopodia at the apical surface of the cell.
Found at: doi:10.1371/journal.pone.0011336.s003 (1.58 MB AVI)
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